Compounds > vatalanib
Page last updated: 2024-09-04

vatalanib and Local Neoplasm Recurrence

vatalanib has been researched along with Local Neoplasm Recurrence in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chamberlain, M; Chandler, JP; Grimm, SA; Helenowski, I; Johnston, SK; McCarthy, K; Mrugala, MM; Muro, K; Rademaker, A; Raizer, JJ; Rice, L1
Baker, AF; Bolejack, V; Burris, H; Crowley, J; Dayyani, F; Dragovich, T; Hidalgo, M; Laheru, D; Raghunand, N; Ritch, P; Rosen, P; Seng, J; Smith, L; Von Hoff, DD1

Trials

2 trial(s) available for vatalanib and Local Neoplasm Recurrence

ArticleYear
A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.
    Journal of neuro-oncology, 2014, Volume: 117, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain; Brain Neoplasms; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Meningioma; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Phthalazines; Pyridines; Salvage Therapy; Time Factors

2014
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001).
    Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Deoxycytidine; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Phthalazines; Prognosis; Pyridines; Survival Rate

2014